ADMI
IRMD icon

Albert D. Mason Inc’s iRadimed IRMD Stock Holding History

Albert D. Mason Inc’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Buy
17,171
+150
+0.9% +$15K 1.07% 32
2025
Q4 		$1.66M Hold
17,021
– – 1.09% 30
2025
Q3 		$1.21M Buy
17,021
+898
+6% +$59.8K 0.79% 55
2025
Q2 		$964K Sell
16,123
-1,146
-7% -$62.8K 0.7% 60
2025
Q1 		$906K Buy
17,269
+333
+2% +$18.7K 0.62% 66
2024
Q4 		$931K Buy
16,936
+2,277
+16% +$120K 0.62% 68
2024
Q3 		$737K Buy
+14,659
New +$676K 0.47% 83

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Albert D. Mason Inc's IRMD Position: Q1 2026 in Review

Albert D. Mason Inc increased its iRadimed (IRMD) stake by 0.88% in Q1 2026, buying an estimated $15K and bringing the position to 17,171 shares worth $1.65M. The position accounts for 1.07% of the portfolio, ranked #32.

Albert D. Mason Inc first reported a position in IRMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.66M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Albert D. Mason Inc held 17,171 shares of iRadimed worth $1.65M as of Q1 2026.
  • Albert D. Mason Inc bought 150 iRadimed shares in Q1 2026, an estimated $15K.
  • iRadimed made up 1.07% of Albert D. Mason Inc's portfolio in Q1 2026, its #32 holding.
  • Albert D. Mason Inc first reported a position in iRadimed in Q3 2024 and has held it in 7 quarters since.
  • Albert D. Mason Inc's iRadimed position peaked at $1.66M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Albert D. Mason Inc's 13F filing for Q1 2026, filed 15 Apr 2026.